7月30日中银创新医疗混合A净值下跌1.45%，近1个月累计上涨20.54%

Core Insights - The latest net value of Zhongyin Innovation Medical Mixed A Fund (007718) is 2.2349 CNY, reflecting a decline of 1.45% [1] - The fund has shown a one-month return of 20.54%, ranking 164 out of 4631 in its category; a six-month return of 88.98%, ranking 20 out of 4484; and a year-to-date return of 85.73%, ranking 27 out of 4447 [1] Fund Holdings - The top ten stock holdings of Zhongyin Innovation Medical Mixed A Fund account for a total of 62.83%, with the following allocations: - Innovent Biologics (8.33%) - Kelun-Biotech (8.15%) - Hengrui Medicine (8.08%) - CanSino Biologics (8.07%) - Sinovac Biotech (6.13%) - Baillie Gifford (5.99%) - BeiGene (5.97%) - Hansoh Pharmaceutical (4.15%) - Rongchang Biologics (4.05%) - CanSino-B (3.91%) [1] Fund Manager Profile - Zheng Ning, the fund manager of Zhongyin Innovation Medical Mixed A Fund, has a background in finance with a master's degree and has held positions at various asset management companies, including as a stock research manager at Taikang Asset Management and a senior researcher at Zhonggeng Fund Management [2] - Zheng Ning has been managing the Zhongyin Innovation Medical Mixed A Fund since July 1, 2022, and has also taken on management roles for other funds within the company [2]